BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 32626939)

  • 1. CircRNA hsa_circ_0070934 functions as a competitive endogenous RNA to regulate HOXB7 expression by sponging miR‑1236‑3p in cutaneous squamous cell carcinoma.
    Zhang DW; Wu HY; Zhu CR; Wu DD
    Int J Oncol; 2020 Aug; 57(2):478-487. PubMed ID: 32626939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
    Wang L; Hou S; Li J; Tian T; Hu R; Yu N
    Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA profiles and the potential involvement of down-expression of hsa_circ_0001360 in cutaneous squamous cell carcinogenesis.
    Chen P; Li C; Huang H; Liang L; Zhang J; Li Q; Wang Q; Zhang S; Zeng K; Zhang X; Liang J
    FEBS Open Bio; 2021 Apr; 11(4):1209-1222. PubMed ID: 33569895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircRNA circ_0067772 aggravates the malignant progression of cutaneous squamous cell carcinoma by regulating miR-1238-3p/FOXG1 axis.
    Li X; Kong Y; Li H; Xu M; Jiang M; Sun W; Xu S
    Genes Genomics; 2021 May; 43(5):491-501. PubMed ID: 33709381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0068631 sponges miR-139-5p to promote the growth and metastasis of cutaneous squamous cell carcinoma by upregulating HOXB7.
    Ji J; Xiong C; Peng J; Zhang N; Zhang Y; Yang H; Zhu W
    Skin Res Technol; 2023 Feb; 29(2):e13248. PubMed ID: 36823512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7.
    Zhao X; Dong W; Luo G; Xie J; Liu J; Yu F
    Mol Cell Biol; 2021 May; 41(6):e0063120. PubMed ID: 33782039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific knockdown of HOXB7 inhibits cutaneous squamous cell carcinoma cell migration and invasion while inducing apoptosis via the Wnt/β-catenin signaling pathway.
    Gao D; Chen HQ
    Am J Physiol Cell Physiol; 2018 Nov; 315(5):C675-C686. PubMed ID: 30067384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing circRNA_001937 may inhibit cutaneous squamous cell carcinoma proliferation and induce apoptosis by preventing the sponging of the miRNA‑597‑3p/FOSL2 pathway.
    Gao L; Jin HJ; Zhang D; Lin Q
    Int J Mol Med; 2020 Nov; 46(5):1653-1660. PubMed ID: 33000177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated circular RNA circ_0070934 facilitates cutaneous squamous cell carcinoma cell growth and invasion by sponging miR-1238 and miR-1247-5p.
    An X; Liu X; Ma G; Li C
    Biochem Biophys Res Commun; 2019 May; 513(2):380-385. PubMed ID: 30967263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0001402 knockdown suppresses the chemoresistance and development of DDP-resistant cutaneous squamous cell carcinoma cells by functioning as a ceRNA for miR-625-5p.
    Li M; Luo M; Liu P; Wang R; Jing H
    Exp Dermatol; 2023 Apr; 32(4):529-541. PubMed ID: 36635223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa_circ_0005085 may suppress cutaneous squamous cell carcinoma growth and metastasis through targeting the miR-186-5p/LAMC1 axis.
    Wang L; Liu Y; Gao Q; Hu R
    Skin Res Technol; 2023 Jun; 29(6):e13321. PubMed ID: 37357644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
    Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0008234 facilitates proliferation of cutaneous squamous cell carcinoma through targeting miR-127-5p to regulate ADCY7.
    Cai L; Wang Y; Wu J; Wu G
    Arch Dermatol Res; 2022 Aug; 314(6):541-551. PubMed ID: 34143288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis.
    Wei D; Sun L; Feng W
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. circ_0001821 Contributes to the Development of Cutaneous Squamous Cell Carcinoma by Regulating MicroRNA-148a-3p/EGFR Axis and Activating Phosphatidylinositol 3-Kinase/Akt Pathway.
    Zhang Z; Deng X
    Mol Cell Biol; 2022 Mar; 42(3):e0008921. PubMed ID: 35191745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis.
    Liu G; Zhou J; Piao Y; Zhao X; Zuo Y; Ji Z
    Aging (Albany NY); 2020 Jun; 12(12):11530-11549. PubMed ID: 32541093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
    Li X; Shen M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging.
    Chen S; Lu S; Yao Y; Chen J; Yang G; Tu L; Zhang Z; Zhang J; Chen L
    Aging (Albany NY); 2020 Jul; 12(14):14329-14340. PubMed ID: 32681720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA-hsa-circ-0000670 promotes gastric cancer progression through the microRNA-384/SIX4 axis.
    Liu P; Cai S; Li N
    Exp Cell Res; 2020 Sep; 394(2):112141. PubMed ID: 32535033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circFADS2 inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-766-3p/HOXA9 axis.
    Zhang Z; Sun H; Hou J; Li L; Wu L
    Histol Histopathol; 2022 Apr; 37(4):335-348. PubMed ID: 34913472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.